詳細検索

詳細検索

お問い合わせ

Global Rnai Drug Delivery Market 2026-2030

Global Rnai Drug Delivery Market 2026-2030


Global Rnai Drug Delivery Market 2026-2030 The global rnai drug delivery market is forecasted to grow by USD 184606.4 mn during 2025-2030, accelerating at a CAGR of 20.0% during the forecast perio... もっと見る

 

 

出版社
TechNavio
テクナビオ
出版年月
2026年10月6日
電子版価格
US$2,500
シングルユーザーライセンス
ライセンス・価格情報/注文方法はこちら
納期
2営業日程度
ページ数
313
言語
英語

英語原文をAIを使って翻訳しています


 

お問い合わせ

お問合せ種類/内容 *

補足が有ればご記入ください
貴社名*
ご担当者名 * 姓 名
メールアドレス *

ページTOPに戻る



図表リスト

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Technology
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibits13: Chart on Overview on factors of disruption
Exhibits14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibits15: Chart on Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Chart on Market characteristics analysis
Exhibits18: Chart on Value chain analysis
Exhibits19: Data Table on Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibits25: Historic Market Size - Data Table on Global RNAi Drug Delivery Market 2020 - 2024 ($ million)
Exhibits26: Historic Market Size - Technology Segment 2020 - 2024 ($ million)
Exhibits27: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibits28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibits30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibits31: Five forces analysis - Comparison between 2025 and 2030
Exhibits32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibits34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibits35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibits36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibits37: Chart on Market condition - Five forces 2025 and 2030
Exhibits38: Chart on Technology - Market share 2025-2030 (%)
Exhibits39: Data Table on Technology - Market share 2025-2030 (%)
Exhibits40: Chart on Comparison by Technology
Exhibits41: Data Table on Comparison by Technology
Exhibits42: Chart on Nanoparticle drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits43: Data Table on Nanoparticle drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits44: Chart on Nanoparticle drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits45: Data Table on Nanoparticle drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits46: Chart on Pulmonary drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits47: Data Table on Pulmonary drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits48: Chart on Pulmonary drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits49: Data Table on Pulmonary drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits50: Chart on Nucleic acid drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits51: Data Table on Nucleic acid drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits52: Chart on Nucleic acid drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits53: Data Table on Nucleic acid drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits54: Chart on Aptamer drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits55: Data Table on Aptamer drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits56: Chart on Aptamer drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits57: Data Table on Aptamer drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits58: Market opportunity by Technology ($ million)
Exhibits59: Data Table on Market opportunity by Technology ($ million)
Exhibits60: Chart on Application - Market share 2025-2030 (%)
Exhibits61: Data Table on Application - Market share 2025-2030 (%)
Exhibits62: Chart on Comparison by Application
Exhibits63: Data Table on Comparison by Application
Exhibits64: Chart on Infectious diseases - Market size and forecast 2025-2030 ($ million)
Exhibits65: Data Table on Infectious diseases - Market size and forecast 2025-2030 ($ million)
Exhibits66: Chart on Infectious diseases - Year-over-year growth 2025-2030 (%)
Exhibits67: Data Table on Infectious diseases - Year-over-year growth 2025-2030 (%)
Exhibits68: Chart on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibits69: Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibits70: Chart on Oncology - Year-over-year growth 2025-2030 (%)
Exhibits71: Data Table on Oncology - Year-over-year growth 2025-2030 (%)
Exhibits72: Chart on Cardiology - Market size and forecast 2025-2030 ($ million)
Exhibits73: Data Table on Cardiology - Market size and forecast 2025-2030 ($ million)
Exhibits74: Chart on Cardiology - Year-over-year growth 2025-2030 (%)
Exhibits75: Data Table on Cardiology - Year-over-year growth 2025-2030 (%)
Exhibits76: Chart on Neurology - Market size and forecast 2025-2030 ($ million)
Exhibits77: Data Table on Neurology - Market size and forecast 2025-2030 ($ million)
Exhibits78: Chart on Neurology - Year-over-year growth 2025-2030 (%)
Exhibits79: Data Table on Neurology - Year-over-year growth 2025-2030 (%)
Exhibits80: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibits81: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibits82: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibits83: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibits84: Market opportunity by Application ($ million)
Exhibits85: Data Table on Market opportunity by Application ($ million)
Exhibits86: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibits87: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibits88: Chart on Comparison by Route of Administration
Exhibits89: Data Table on Comparison by Route of Administration
Exhibits90: Chart on Intravenous delivery - Market size and forecast 2025-2030 ($ million)
Exhibits91: Data Table on Intravenous delivery - Market size and forecast 2025-2030 ($ million)
Exhibits92: Chart on Intravenous delivery - Year-over-year growth 2025-2030 (%)
Exhibits93: Data Table on Intravenous delivery - Year-over-year growth 2025-2030 (%)
Exhibits94: Chart on Subcutaneous delivery - Market size and forecast 2025-2030 ($ million)
Exhibits95: Data Table on Subcutaneous delivery - Market size and forecast 2025-2030 ($ million)
Exhibits96: Chart on Subcutaneous delivery - Year-over-year growth 2025-2030 (%)
Exhibits97: Data Table on Subcutaneous delivery - Year-over-year growth 2025-2030 (%)
Exhibits98: Chart on Intrathecal - Market size and forecast 2025-2030 ($ million)
Exhibits99: Data Table on Intrathecal - Market size and forecast 2025-2030 ($ million)
Exhibits100: Chart on Intrathecal - Year-over-year growth 2025-2030 (%)
Exhibits101: Data Table on Intrathecal - Year-over-year growth 2025-2030 (%)
Exhibits102: Chart on Intramuscular - Market size and forecast 2025-2030 ($ million)
Exhibits103: Data Table on Intramuscular - Market size and forecast 2025-2030 ($ million)
Exhibits104: Chart on Intramuscular - Year-over-year growth 2025-2030 (%)
Exhibits105: Data Table on Intramuscular - Year-over-year growth 2025-2030 (%)
Exhibits106: Market opportunity by Route of Administration ($ million)
Exhibits107: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits109: Chart on Market share by geography 2025-2030 (%)
Exhibits110: Data Table on Market share by geography 2025-2030 (%)
Exhibits111: Chart on Geographic comparison
Exhibits112: Data Table on Geographic comparison
Exhibits113: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibits114: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibits115: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibits116: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibits117: Chart on Regional Comparison - North America
Exhibits118: Data Table on Regional Comparison - North America
Exhibits119: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibits120: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibits121: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibits122: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibits123: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibits124: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibits125: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibits126: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibits127: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibits128: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibits129: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibits130: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibits131: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibits132: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibits133: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibits134: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibits135: Chart on Regional Comparison - Europe
Exhibits136: Data Table on Regional Comparison - Europe
Exhibits137: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibits138: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibits139: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibits140: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibits141: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibits142: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibits143: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibits144: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibits145: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibits146: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibits147: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibits148: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibits149: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibits150: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibits151: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibits152: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibits153: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibits154: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibits155: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibits156: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibits157: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibits158: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibits159: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibits160: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibits161: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibits162: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibits163: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibits164: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibits165: Chart on Regional Comparison - Asia
Exhibits166: Data Table on Regional Comparison - Asia
Exhibits167: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibits168: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibits169: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibits170: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibits171: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibits172: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibits173: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibits174: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibits175: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibits176: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibits177: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibits178: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibits179: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibits180: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibits181: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibits182: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibits183: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibits184: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibits185: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibits186: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibits187: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibits188: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibits189: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibits190: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibits191: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibits192: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibits193: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibits194: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibits195: Chart on Regional Comparison - Rest of World (ROW)
Exhibits196: Data Table on Regional Comparison - Rest of World (ROW)
Exhibits197: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibits198: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibits199: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibits200: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibits201: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibits202: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibits203: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibits204: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibits205: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibits206: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibits207: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibits208: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibits209: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibits210: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibits211: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibits212: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibits213: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibits214: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibits215: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibits216: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibits217: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibits218: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibits219: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibits220: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibits221: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibits222: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibits223: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibits224: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibits225: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibits226: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibits227: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibits228: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibits229: Market opportunity by geography ($ million)
Exhibits230: Data Tables on Market opportunity by geography ($ million)
Exhibits231: Impact of drivers and challenges in 2025 and 2030
Exhibits232: Overview on criticality of inputs and factors of differentiation
Exhibits233: Overview on factors of disruption
Exhibits234: Impact of key risks on business
Exhibits235: Companies covered
Exhibits236: Company ranking index
Exhibits237: Matrix on companies position and classification
Exhibits238: Arrowhead Pharmaceuticals Inc. - Overview
Exhibits239: Arrowhead Pharmaceuticals Inc. - Product / Service
Exhibits240: Arrowhead Pharmaceuticals Inc. - Key offerings
Exhibits241: SWOT
Exhibits242: BioNTech SE - Overview
Exhibits243: BioNTech SE - Product / Service
Exhibits244: BioNTech SE - Key offerings
Exhibits245: SWOT
Exhibits246: Calando Pharmaceuticals Inc. - Overview
Exhibits247: Calando Pharmaceuticals Inc. - Product / Service
Exhibits248: Calando Pharmaceuticals Inc. - Key offerings
Exhibits249: SWOT
Exhibits250: Enzene Biosciences Ltd. - Overview
Exhibits251: Enzene Biosciences Ltd. - Product / Service
Exhibits252: Enzene Biosciences Ltd. - Key offerings
Exhibits253: SWOT
Exhibits254: Genevant Sciences Corp. - Overview
Exhibits255: Genevant Sciences Corp. - Product / Service
Exhibits256: Genevant Sciences Corp. - Key offerings
Exhibits257: SWOT
Exhibits258: Ionis Pharmaceuticals Inc. - Overview
Exhibits259: Ionis Pharmaceuticals Inc. - Product / Service
Exhibits260: Ionis Pharmaceuticals Inc. - Key offerings
Exhibits261: SWOT
Exhibits262: Merck and Co. Inc. - Overview
Exhibits263: Merck and Co. Inc. - Business segments
Exhibits264: Merck and Co. Inc. - Key news
Exhibits265: Merck and Co. Inc. - Key offerings
Exhibits266: Merck and Co. Inc. - Segment focus
Exhibits267: SWOT
Exhibits268: Novartis AG - Overview
Exhibits269: Novartis AG - Business segments
Exhibits270: Novartis AG - Key news
Exhibits271: Novartis AG - Key offerings
Exhibits272: Novartis AG - Segment focus
Exhibits273: SWOT
Exhibits274: OliX Pharmaceuticals Inc. - Overview
Exhibits275: OliX Pharmaceuticals Inc. - Product / Service
Exhibits276: OliX Pharmaceuticals Inc. - Key offerings
Exhibits277: SWOT
Exhibits278: Pfizer Inc. - Overview
Exhibits279: Pfizer Inc. - Business segments
Exhibits280: Pfizer Inc. - Key news
Exhibits281: Pfizer Inc. - Key offerings
Exhibits282: Pfizer Inc. - Segment focus
Exhibits283: SWOT
Exhibits284: Sanofi SA - Overview
Exhibits285: Sanofi SA - Business segments
Exhibits286: Sanofi SA - Key news
Exhibits287: Sanofi SA - Key offerings
Exhibits288: Sanofi SA - Segment focus
Exhibits289: SWOT
Exhibits290: Switch Therapeutics Inc. - Overview
Exhibits291: Switch Therapeutics Inc. - Product / Service
Exhibits292: Switch Therapeutics Inc. - Key offerings
Exhibits293: SWOT
Exhibits294: Sylentis S.A. - Overview
Exhibits295: Sylentis S.A. - Product / Service
Exhibits296: Sylentis S.A. - Key offerings
Exhibits297: SWOT
Exhibits298: Takeda Pharmaceutical Ltd. - Overview
Exhibits299: Takeda Pharmaceutical Ltd. - Business segments
Exhibits300: Takeda Pharmaceutical Ltd. - Key news
Exhibits301: Takeda Pharmaceutical Ltd. - Key offerings
Exhibits302: Takeda Pharmaceutical Ltd. - Segment focus
Exhibits303: SWOT
Exhibits304: Vir Biotechnology Inc. - Overview
Exhibits305: Vir Biotechnology Inc. - Product / Service
Exhibits306: Vir Biotechnology Inc. - Key offerings
Exhibits307: SWOT
Exhibits308: Inclusions checklist
Exhibits309: Exclusions checklist
Exhibits310: Currency conversion rates for US$
Exhibits311: Research methodology
Exhibits312: Information sources
Exhibits313: Data validation
Exhibits314: Validation techniques employed for market sizing
Exhibits315: Data synthesis
Exhibits316: 360 degree market analysis
Exhibits317: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Rnai Drug Delivery Market 2026-2030
The global rnai drug delivery market is forecasted to grow by USD 184606.4 mn during 2025-2030, accelerating at a CAGR of 20.0% during the forecast period. The report on the global rnai drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by focused delivery technologies enable precision genetic silencing, expanding chronic disease burdens drive target validation, strategic corporate collaborations accelerate early commercial pipelines.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data. For further information on this report, please visit -

Technavio's global rnai drug delivery market is segmented as below:
By Technology
• Nanoparticle drug delivery
• Pulmonary drug delivery
• Nucleic acid drug delivery
• Aptamer drug delivery
By Application
• Infectious diseases
• Oncology
• Cardiology
• Neurology
• Others
By Route Of Administration
• Intravenous delivery
• Subcutaneous delivery
• Intrathecal
• Intramuscular
Geography
• North America
• US
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)
This study identifies the next generation conjugation formulations dominate pipeline development as one of the prime reasons driving the global rnai drug delivery market growth during the next few years. Also, strategic out licensing partnerships accelerate enterprise commercialization and central nervous system delivery research expands neurological applications will lead to sizable demand in the market.
The report on the global rnai drug delivery market covers the following areas:
• Global rnai drug delivery market sizing
• Global rnai drug delivery market forecast
• Global rnai drug delivery market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global rnai drug delivery market vendors that include Acuitas Therapeutics, ADARx Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Aptadel Therapeutics, Arbutus Biopharma Corp., Arrowhead Pharmaceuticals Inc., BioNTech SE, Calando Pharmaceuticals Inc., Enzene Biosciences Ltd., Genevant Sciences Corp., Ionis Pharmaceuticals Inc., Merck and Co. Inc., Novartis AG, OliX Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, Switch Therapeutics Inc., Sylentis S.A., Takeda Pharmaceutical Ltd., Vir Biotechnology Inc.. Also, the global rnai drug delivery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

ページTOPに戻る


Table of Contents

1 Executive Summary
1.1 Market overview
• Executive Summary - Chart on Market Overview
• Executive Summary - Data Table on Market Overview
• Executive Summary - Chart on Global Market Characteristics
• Executive Summary - Chart on Market by Geography
• Executive Summary - Chart on Market Segmentation by Technology
• Executive Summary - Chart on Market Segmentation by Application
• Executive Summary - Chart on Market Segmentation by Route of Administration
• Executive Summary - Chart on Incremental Growth
• Executive Summary - Data Table on Incremental Growth
• Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
• Chart on Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
• Chart on Overview on factors of disruption
2.4 Impact of drivers and challenges
• Chart on Impact of drivers and challenges in 2025 and 2030

3 Market Landscape
3.1 Market ecosystem
• Chart on Parent Market
• Data Table on - Parent Market
3.2 Market characteristics
• Chart on Market characteristics analysis
3.3 Value chain analysis
• Chart on Value chain analysis

4 Market Sizing
4.1 Market definition
• Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
• Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
• Chart on Global - Market size and forecast 2025-2030 ($ million)
• Data Table on Global - Market size and forecast 2025-2030 ($ million)
• Chart on Global Market: Year-over-year growth 2025-2030 (%)
• Data Table on Global Market: Year-over-year growth 2025-2030 (%)

5 Historic Market Size
5.1 Global RNAi Drug Delivery Market 2020 - 2024
• Historic Market Size - Data Table on Global RNAi Drug Delivery Market 2020 - 2024 ($ million)
5.2 Technology segment analysis 2020 - 2024
• Historic Market Size - Technology Segment 2020 - 2024 ($ million)
5.3 Application segment analysis 2020 - 2024
• Historic Market Size - Application Segment 2020 - 2024 ($ million)
5.4 Route of Administration segment analysis 2020 - 2024
• Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
• Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.6 Country segment analysis 2020 - 2024
• Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis
6.1 Impact of AI on global RNAi drug delivery market
6.2 Impact of geopolitical conflicts on global RNAi drug delivery market

7 Five Forces Analysis
7.1 Five forces summary
• Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
• Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
• Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
• Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
• Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
• Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
• Chart on Market condition - Five forces 2025 and 2030

8 Market Segmentation by Technology
8.1 Market segments
• Chart on Technology - Market share 2025-2030 (%)
• Data Table on Technology - Market share 2025-2030 (%)
8.2 Comparison by Technology
• Chart on Comparison by Technology
• Data Table on Comparison by Technology
8.3 Nanoparticle drug delivery - Market size and forecast 2025-2030
• Chart on Nanoparticle drug delivery - Market size and forecast 2025-2030 ($ million)
• Data Table on Nanoparticle drug delivery - Market size and forecast 2025-2030 ($ million)
• Chart on Nanoparticle drug delivery - Year-over-year growth 2025-2030 (%)
• Data Table on Nanoparticle drug delivery - Year-over-year growth 2025-2030 (%)
8.4 Pulmonary drug delivery - Market size and forecast 2025-2030
• Chart on Pulmonary drug delivery - Market size and forecast 2025-2030 ($ million)
• Data Table on Pulmonary drug delivery - Market size and forecast 2025-2030 ($ million)
• Chart on Pulmonary drug delivery - Year-over-year growth 2025-2030 (%)
• Data Table on Pulmonary drug delivery - Year-over-year growth 2025-2030 (%)
8.5 Nucleic acid drug delivery - Market size and forecast 2025-2030
• Chart on Nucleic acid drug delivery - Market size and forecast 2025-2030 ($ million)
• Data Table on Nucleic acid drug delivery - Market size and forecast 2025-2030 ($ million)
• Chart on Nucleic acid drug delivery - Year-over-year growth 2025-2030 (%)
• Data Table on Nucleic acid drug delivery - Year-over-year growth 2025-2030 (%)
8.6 Aptamer drug delivery - Market size and forecast 2025-2030
• Chart on Aptamer drug delivery - Market size and forecast 2025-2030 ($ million)
• Data Table on Aptamer drug delivery - Market size and forecast 2025-2030 ($ million)
• Chart on Aptamer drug delivery - Year-over-year growth 2025-2030 (%)
• Data Table on Aptamer drug delivery - Year-over-year growth 2025-2030 (%)
8.7 Market opportunity by Technology
• Market opportunity by Technology ($ million)
• Data Table on Market opportunity by Technology ($ million)

9 Market Segmentation by Application
9.1 Market segments
• Chart on Application - Market share 2025-2030 (%)
• Data Table on Application - Market share 2025-2030 (%)
9.2 Comparison by Application
• Chart on Comparison by Application
• Data Table on Comparison by Application
9.3 Infectious diseases - Market size and forecast 2025-2030
• Chart on Infectious diseases - Market size and forecast 2025-2030 ($ million)
• Data Table on Infectious diseases - Market size and forecast 2025-2030 ($ million)
• Chart on Infectious diseases - Year-over-year growth 2025-2030 (%)
• Data Table on Infectious diseases - Year-over-year growth 2025-2030 (%)
9.4 Oncology - Market size and forecast 2025-2030
• Chart on Oncology - Market size and forecast 2025-2030 ($ million)
• Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
• Chart on Oncology - Year-over-year growth 2025-2030 (%)
• Data Table on Oncology - Year-over-year growth 2025-2030 (%)
9.5 Cardiology - Market size and forecast 2025-2030
• Chart on Cardiology - Market size and forecast 2025-2030 ($ million)
• Data Table on Cardiology - Market size and forecast 2025-2030 ($ million)
• Chart on Cardiology - Year-over-year growth 2025-2030 (%)
• Data Table on Cardiology - Year-over-year growth 2025-2030 (%)
9.6 Neurology - Market size and forecast 2025-2030
• Chart on Neurology - Market size and forecast 2025-2030 ($ million)
• Data Table on Neurology - Market size and forecast 2025-2030 ($ million)
• Chart on Neurology - Year-over-year growth 2025-2030 (%)
• Data Table on Neurology - Year-over-year growth 2025-2030 (%)
9.7 Others - Market size and forecast 2025-2030
• Chart on Others - Market size and forecast 2025-2030 ($ million)
• Data Table on Others - Market size and forecast 2025-2030 ($ million)
• Chart on Others - Year-over-year growth 2025-2030 (%)
• Data Table on Others - Year-over-year growth 2025-2030 (%)
9.8 Market opportunity by Application
• Market opportunity by Application ($ million)
• Data Table on Market opportunity by Application ($ million)

10 Market Segmentation by Route of Administration
10.1 Market segments
• Chart on Route of Administration - Market share 2025-2030 (%)
• Data Table on Route of Administration - Market share 2025-2030 (%)
10.2 Comparison by Route of Administration
• Chart on Comparison by Route of Administration
• Data Table on Comparison by Route of Administration
10.3 Intravenous delivery - Market size and forecast 2025-2030
• Chart on Intravenous delivery - Market size and forecast 2025-2030 ($ million)
• Data Table on Intravenous delivery - Market size and forecast 2025-2030 ($ million)
• Chart on Intravenous delivery - Year-over-year growth 2025-2030 (%)
• Data Table on Intravenous delivery - Year-over-year growth 2025-2030 (%)
10.4 Subcutaneous delivery - Market size and forecast 2025-2030
• Chart on Subcutaneous delivery - Market size and forecast 2025-2030 ($ million)
• Data Table on Subcutaneous delivery - Market size and forecast 2025-2030 ($ million)
• Chart on Subcutaneous delivery - Year-over-year growth 2025-2030 (%)
• Data Table on Subcutaneous delivery - Year-over-year growth 2025-2030 (%)
10.5 Intrathecal - Market size and forecast 2025-2030
• Chart on Intrathecal - Market size and forecast 2025-2030 ($ million)
• Data Table on Intrathecal - Market size and forecast 2025-2030 ($ million)
• Chart on Intrathecal - Year-over-year growth 2025-2030 (%)
• Data Table on Intrathecal - Year-over-year growth 2025-2030 (%)
10.6 Intramuscular - Market size and forecast 2025-2030
• Chart on Intramuscular - Market size and forecast 2025-2030 ($ million)
• Data Table on Intramuscular - Market size and forecast 2025-2030 ($ million)
• Chart on Intramuscular - Year-over-year growth 2025-2030 (%)
• Data Table on Intramuscular - Year-over-year growth 2025-2030 (%)
10.7 Market opportunity by Route of Administration
• Market opportunity by Route of Administration ($ million)
• Data Table on Market opportunity by Route of Administration ($ million)

11 Customer Landscape
11.1 Customer landscape overview
• Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape
12.1 Geographic segmentation
• Chart on Market share by geography 2025-2030 (%)
• Data Table on Market share by geography 2025-2030 (%)
12.2 Geographic comparison
• Chart on Geographic comparison
• Data Table on Geographic comparison
12.3 North America - Market size and forecast 2025-2030
• Chart on North America - Market size and forecast 2025-2030 ($ million)
• Data Table on North America - Market size and forecast 2025-2030 ($ million)
• Chart on North America - Year-over-year growth 2025-2030 (%)
• Data Table on North America - Year-over-year growth 2025-2030 (%)
• Chart on Regional Comparison - North America
• Data Table on Regional Comparison - North America
12.3.1 US - Market size and forecast 2025-2030
• Chart on US - Market size and forecast 2025-2030 ($ million)
• Data Table on US - Market size and forecast 2025-2030 ($ million)
• Chart on US - Year-over-year growth 2025-2030 (%)
• Data Table on US - Year-over-year growth 2025-2030 (%)
12.3.2 Canada - Market size and forecast 2025-2030
• Chart on Canada - Market size and forecast 2025-2030 ($ million)
• Data Table on Canada - Market size and forecast 2025-2030 ($ million)
• Chart on Canada - Year-over-year growth 2025-2030 (%)
• Data Table on Canada - Year-over-year growth 2025-2030 (%)
12.3.3 Mexico - Market size and forecast 2025-2030
• Chart on Mexico - Market size and forecast 2025-2030 ($ million)
• Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
• Chart on Mexico - Year-over-year growth 2025-2030 (%)
• Data Table on Mexico - Year-over-year growth 2025-2030 (%)
12.4 Europe - Market size and forecast 2025-2030
• Chart on Europe - Market size and forecast 2025-2030 ($ million)
• Data Table on Europe - Market size and forecast 2025-2030 ($ million)
• Chart on Europe - Year-over-year growth 2025-2030 (%)
• Data Table on Europe - Year-over-year growth 2025-2030 (%)
• Chart on Regional Comparison - Europe
• Data Table on Regional Comparison - Europe
12.4.1 Germany - Market size and forecast 2025-2030
• Chart on Germany - Market size and forecast 2025-2030 ($ million)
• Data Table on Germany - Market size and forecast 2025-2030 ($ million)
• Chart on Germany - Year-over-year growth 2025-2030 (%)
• Data Table on Germany - Year-over-year growth 2025-2030 (%)
12.4.2 UK - Market size and forecast 2025-2030
• Chart on UK - Market size and forecast 2025-2030 ($ million)
• Data Table on UK - Market size and forecast 2025-2030 ($ million)
• Chart on UK - Year-over-year growth 2025-2030 (%)
• Data Table on UK - Year-over-year growth 2025-2030 (%)
12.4.3 France - Market size and forecast 2025-2030
• Chart on France - Market size and forecast 2025-2030 ($ million)
• Data Table on France - Market size and forecast 2025-2030 ($ million)
• Chart on France - Year-over-year growth 2025-2030 (%)
• Data Table on France - Year-over-year growth 2025-2030 (%)
12.4.4 Italy - Market size and forecast 2025-2030
• Chart on Italy - Market size and forecast 2025-2030 ($ million)
• Data Table on Italy - Market size and forecast 2025-2030 ($ million)
• Chart on Italy - Year-over-year growth 2025-2030 (%)
• Data Table on Italy - Year-over-year growth 2025-2030 (%)
12.4.5 Spain - Market size and forecast 2025-2030
• Chart on Spain - Market size and forecast 2025-2030 ($ million)
• Data Table on Spain - Market size and forecast 2025-2030 ($ million)
• Chart on Spain - Year-over-year growth 2025-2030 (%)
• Data Table on Spain - Year-over-year growth 2025-2030 (%)
12.4.6 The Netherlands - Market size and forecast 2025-2030
• Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
• Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
• Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
• Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
12.5 Asia - Market size and forecast 2025-2030
• Chart on Asia - Market size and forecast 2025-2030 ($ million)
• Data Table on Asia - Market size and forecast 2025-2030 ($ million)
• Chart on Asia - Year-over-year growth 2025-2030 (%)
• Data Table on Asia - Year-over-year growth 2025-2030 (%)
• Chart on Regional Comparison - Asia
• Data Table on Regional Comparison - Asia
12.5.1 China - Market size and forecast 2025-2030
• Chart on China - Market size and forecast 2025-2030 ($ million)
• Data Table on China - Market size and forecast 2025-2030 ($ million)
• Chart on China - Year-over-year growth 2025-2030 (%)
• Data Table on China - Year-over-year growth 2025-2030 (%)
12.5.2 India - Market size and forecast 2025-2030
• Chart on India - Market size and forecast 2025-2030 ($ million)
• Data Table on India - Market size and forecast 2025-2030 ($ million)
• Chart on India - Year-over-year growth 2025-2030 (%)
• Data Table on India - Year-over-year growth 2025-2030 (%)
12.5.3 Japan - Market size and forecast 2025-2030
• Chart on Japan - Market size and forecast 2025-2030 ($ million)
• Data Table on Japan - Market size and forecast 2025-2030 ($ million)
• Chart on Japan - Year-over-year growth 2025-2030 (%)
• Data Table on Japan - Year-over-year growth 2025-2030 (%)
12.5.4 South Korea - Market size and forecast 2025-2030
• Chart on South Korea - Market size and forecast 2025-2030 ($ million)
• Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
• Chart on South Korea - Year-over-year growth 2025-2030 (%)
• Data Table on South Korea - Year-over-year growth 2025-2030 (%)
12.5.5 Indonesia - Market size and forecast 2025-2030
• Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
• Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
• Chart on Indonesia - Year-over-year growth 2025-2030 (%)
• Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
12.5.6 Thailand - Market size and forecast 2025-2030
• Chart on Thailand - Market size and forecast 2025-2030 ($ million)
• Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
• Chart on Thailand - Year-over-year growth 2025-2030 (%)
• Data Table on Thailand - Year-over-year growth 2025-2030 (%)
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
• Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
• Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
• Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
• Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
• Chart on Regional Comparison - Rest of World (ROW)
• Data Table on Regional Comparison - Rest of World (ROW)
12.6.1 Brazil - Market size and forecast 2025-2030
• Chart on Brazil - Market size and forecast 2025-2030 ($ million)
• Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
• Chart on Brazil - Year-over-year growth 2025-2030 (%)
• Data Table on Brazil - Year-over-year growth 2025-2030 (%)
12.6.2 Australia - Market size and forecast 2025-2030
• Chart on Australia - Market size and forecast 2025-2030 ($ million)
• Data Table on Australia - Market size and forecast 2025-2030 ($ million)
• Chart on Australia - Year-over-year growth 2025-2030 (%)
• Data Table on Australia - Year-over-year growth 2025-2030 (%)
12.6.3 UAE - Market size and forecast 2025-2030
• Chart on UAE - Market size and forecast 2025-2030 ($ million)
• Data Table on UAE - Market size and forecast 2025-2030 ($ million)
• Chart on UAE - Year-over-year growth 2025-2030 (%)
• Data Table on UAE - Year-over-year growth 2025-2030 (%)
12.6.4 Saudi Arabia - Market size and forecast 2025-2030
• Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
• Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
• Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
• Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
12.6.5 Turkey - Market size and forecast 2025-2030
• Chart on Turkey - Market size and forecast 2025-2030 ($ million)
• Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
• Chart on Turkey - Year-over-year growth 2025-2030 (%)
• Data Table on Turkey - Year-over-year growth 2025-2030 (%)
12.6.6 South Africa - Market size and forecast 2025-2030
• Chart on South Africa - Market size and forecast 2025-2030 ($ million)
• Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
• Chart on South Africa - Year-over-year growth 2025-2030 (%)
• Data Table on South Africa - Year-over-year growth 2025-2030 (%)
12.6.7 Israel - Market size and forecast 2025-2030
• Chart on Israel - Market size and forecast 2025-2030 ($ million)
• Data Table on Israel - Market size and forecast 2025-2030 ($ million)
• Chart on Israel - Year-over-year growth 2025-2030 (%)
• Data Table on Israel - Year-over-year growth 2025-2030 (%)
12.6.8 Argentina - Market size and forecast 2025-2030
• Chart on Argentina - Market size and forecast 2025-2030 ($ million)
• Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
• Chart on Argentina - Year-over-year growth 2025-2030 (%)
• Data Table on Argentina - Year-over-year growth 2025-2030 (%)
12.7 Market opportunity by geography
• Market opportunity by geography ($ million)
• Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity
13.1 Market drivers
• Focused delivery technologies enable precision genetic silencing
• Expanding chronic disease burdens drive target validation
• Strategic corporate collaborations accelerate early commercial pipelines
13.2 Market challenges
• Targeted extrahepatic tissue delivery barriers restrict reach
• High manufacturing overhead and oligonucleotide synthesis costs
• Transient gene silencing requires persistent lifetime dosing
13.3 Impact of drivers and challenges
• Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
• Next generation conjugation formulations dominate pipeline development
• Strategic out licensing partnerships accelerate enterprise commercialization
• Central nervous system delivery research expands neurological applications

14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
• Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
• Overview on factors of disruption
14.4 Industry risks
• Impact of key risks on business

15 Competitive Analysis
15.1 Companies profiled
• Companies covered
15.2 Company ranking index
• Company ranking index
15.3 Market positioning of companies
• Matrix on companies position and classification
15.4 Arrowhead Pharmaceuticals Inc.
• Arrowhead Pharmaceuticals Inc. - Overview
• Arrowhead Pharmaceuticals Inc. - Product / Service
• Arrowhead Pharmaceuticals Inc. - Key offerings
• SWOT
15.5 BioNTech SE
• BioNTech SE - Overview
• BioNTech SE - Product / Service
• BioNTech SE - Key offerings
• SWOT
15.6 Calando Pharmaceuticals Inc.
• Calando Pharmaceuticals Inc. - Overview
• Calando Pharmaceuticals Inc. - Product / Service
• Calando Pharmaceuticals Inc. - Key offerings
• SWOT
15.7 Enzene Biosciences Ltd.
• Enzene Biosciences Ltd. - Overview
• Enzene Biosciences Ltd. - Product / Service
• Enzene Biosciences Ltd. - Key offerings
• SWOT
15.8 Genevant Sciences Corp.
• Genevant Sciences Corp. - Overview
• Genevant Sciences Corp. - Product / Service
• Genevant Sciences Corp. - Key offerings
• SWOT
15.9 Ionis Pharmaceuticals Inc.
• Ionis Pharmaceuticals Inc. - Overview
• Ionis Pharmaceuticals Inc. - Product / Service
• Ionis Pharmaceuticals Inc. - Key offerings
• SWOT
15.10 Merck and Co. Inc.
• Merck and Co. Inc. - Overview
• Merck and Co. Inc. - Business segments
• Merck and Co. Inc. - Key news
• Merck and Co. Inc. - Key offerings
• Merck and Co. Inc. - Segment focus
• SWOT
15.11 Novartis AG
• Novartis AG - Overview
• Novartis AG - Business segments
• Novartis AG - Key news
• Novartis AG - Key offerings
• Novartis AG - Segment focus
• SWOT
15.12 OliX Pharmaceuticals Inc.
• OliX Pharmaceuticals Inc. - Overview
• OliX Pharmaceuticals Inc. - Product / Service
• OliX Pharmaceuticals Inc. - Key offerings
• SWOT
15.13 Pfizer Inc.
• Pfizer Inc. - Overview
• Pfizer Inc. - Business segments
• Pfizer Inc. - Key news
• Pfizer Inc. - Key offerings
• Pfizer Inc. - Segment focus
• SWOT
15.14 Sanofi SA
• Sanofi SA - Overview
• Sanofi SA - Business segments
• Sanofi SA - Key news
• Sanofi SA - Key offerings
• Sanofi SA - Segment focus
• SWOT
15.15 Switch Therapeutics Inc.
• Switch Therapeutics Inc. - Overview
• Switch Therapeutics Inc. - Product / Service
• Switch Therapeutics Inc. - Key offerings
• SWOT
15.16 Sylentis S.A.
• Sylentis S.A. - Overview
• Sylentis S.A. - Product / Service
• Sylentis S.A. - Key offerings
• SWOT
15.17 Takeda Pharmaceutical Ltd.
• Takeda Pharmaceutical Ltd. - Overview
• Takeda Pharmaceutical Ltd. - Business segments
• Takeda Pharmaceutical Ltd. - Key news
• Takeda Pharmaceutical Ltd. - Key offerings
• Takeda Pharmaceutical Ltd. - Segment focus
• SWOT
15.18 Vir Biotechnology Inc.
• Vir Biotechnology Inc. - Overview
• Vir Biotechnology Inc. - Product / Service
• Vir Biotechnology Inc. - Key offerings
• SWOT

16 Appendix
16.1 Scope of the report
• Market definition
• Objectives
• Notes and caveats
16.2 Inclusions and exclusions checklist
• Inclusions checklist
• Exclusions checklist
16.3 Currency conversion rates for US$
• Currency conversion rates for US$
16.4 Research methodology
• Research methodology
16.5 Data procurement
• Information sources
16.6 Data validation
• Data validation
16.7 Validation techniques employed for market sizing
• Validation techniques employed for market sizing
16.8 Data synthesis
• Data synthesis
16.9 360 degree market analysis
• 360 degree market analysis
16.10 List of abbreviations
• List of abbreviations

ページTOPに戻る



List of Tables/Graphs

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Technology
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibits13: Chart on Overview on factors of disruption
Exhibits14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibits15: Chart on Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Chart on Market characteristics analysis
Exhibits18: Chart on Value chain analysis
Exhibits19: Data Table on Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibits25: Historic Market Size - Data Table on Global RNAi Drug Delivery Market 2020 - 2024 ($ million)
Exhibits26: Historic Market Size - Technology Segment 2020 - 2024 ($ million)
Exhibits27: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibits28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibits30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibits31: Five forces analysis - Comparison between 2025 and 2030
Exhibits32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibits34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibits35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibits36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibits37: Chart on Market condition - Five forces 2025 and 2030
Exhibits38: Chart on Technology - Market share 2025-2030 (%)
Exhibits39: Data Table on Technology - Market share 2025-2030 (%)
Exhibits40: Chart on Comparison by Technology
Exhibits41: Data Table on Comparison by Technology
Exhibits42: Chart on Nanoparticle drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits43: Data Table on Nanoparticle drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits44: Chart on Nanoparticle drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits45: Data Table on Nanoparticle drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits46: Chart on Pulmonary drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits47: Data Table on Pulmonary drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits48: Chart on Pulmonary drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits49: Data Table on Pulmonary drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits50: Chart on Nucleic acid drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits51: Data Table on Nucleic acid drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits52: Chart on Nucleic acid drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits53: Data Table on Nucleic acid drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits54: Chart on Aptamer drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits55: Data Table on Aptamer drug delivery - Market size and forecast 2025-2030 ($ million)
Exhibits56: Chart on Aptamer drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits57: Data Table on Aptamer drug delivery - Year-over-year growth 2025-2030 (%)
Exhibits58: Market opportunity by Technology ($ million)
Exhibits59: Data Table on Market opportunity by Technology ($ million)
Exhibits60: Chart on Application - Market share 2025-2030 (%)
Exhibits61: Data Table on Application - Market share 2025-2030 (%)
Exhibits62: Chart on Comparison by Application
Exhibits63: Data Table on Comparison by Application
Exhibits64: Chart on Infectious diseases - Market size and forecast 2025-2030 ($ million)
Exhibits65: Data Table on Infectious diseases - Market size and forecast 2025-2030 ($ million)
Exhibits66: Chart on Infectious diseases - Year-over-year growth 2025-2030 (%)
Exhibits67: Data Table on Infectious diseases - Year-over-year growth 2025-2030 (%)
Exhibits68: Chart on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibits69: Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibits70: Chart on Oncology - Year-over-year growth 2025-2030 (%)
Exhibits71: Data Table on Oncology - Year-over-year growth 2025-2030 (%)
Exhibits72: Chart on Cardiology - Market size and forecast 2025-2030 ($ million)
Exhibits73: Data Table on Cardiology - Market size and forecast 2025-2030 ($ million)
Exhibits74: Chart on Cardiology - Year-over-year growth 2025-2030 (%)
Exhibits75: Data Table on Cardiology - Year-over-year growth 2025-2030 (%)
Exhibits76: Chart on Neurology - Market size and forecast 2025-2030 ($ million)
Exhibits77: Data Table on Neurology - Market size and forecast 2025-2030 ($ million)
Exhibits78: Chart on Neurology - Year-over-year growth 2025-2030 (%)
Exhibits79: Data Table on Neurology - Year-over-year growth 2025-2030 (%)
Exhibits80: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibits81: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibits82: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibits83: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibits84: Market opportunity by Application ($ million)
Exhibits85: Data Table on Market opportunity by Application ($ million)
Exhibits86: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibits87: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibits88: Chart on Comparison by Route of Administration
Exhibits89: Data Table on Comparison by Route of Administration
Exhibits90: Chart on Intravenous delivery - Market size and forecast 2025-2030 ($ million)
Exhibits91: Data Table on Intravenous delivery - Market size and forecast 2025-2030 ($ million)
Exhibits92: Chart on Intravenous delivery - Year-over-year growth 2025-2030 (%)
Exhibits93: Data Table on Intravenous delivery - Year-over-year growth 2025-2030 (%)
Exhibits94: Chart on Subcutaneous delivery - Market size and forecast 2025-2030 ($ million)
Exhibits95: Data Table on Subcutaneous delivery - Market size and forecast 2025-2030 ($ million)
Exhibits96: Chart on Subcutaneous delivery - Year-over-year growth 2025-2030 (%)
Exhibits97: Data Table on Subcutaneous delivery - Year-over-year growth 2025-2030 (%)
Exhibits98: Chart on Intrathecal - Market size and forecast 2025-2030 ($ million)
Exhibits99: Data Table on Intrathecal - Market size and forecast 2025-2030 ($ million)
Exhibits100: Chart on Intrathecal - Year-over-year growth 2025-2030 (%)
Exhibits101: Data Table on Intrathecal - Year-over-year growth 2025-2030 (%)
Exhibits102: Chart on Intramuscular - Market size and forecast 2025-2030 ($ million)
Exhibits103: Data Table on Intramuscular - Market size and forecast 2025-2030 ($ million)
Exhibits104: Chart on Intramuscular - Year-over-year growth 2025-2030 (%)
Exhibits105: Data Table on Intramuscular - Year-over-year growth 2025-2030 (%)
Exhibits106: Market opportunity by Route of Administration ($ million)
Exhibits107: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits109: Chart on Market share by geography 2025-2030 (%)
Exhibits110: Data Table on Market share by geography 2025-2030 (%)
Exhibits111: Chart on Geographic comparison
Exhibits112: Data Table on Geographic comparison
Exhibits113: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibits114: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibits115: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibits116: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibits117: Chart on Regional Comparison - North America
Exhibits118: Data Table on Regional Comparison - North America
Exhibits119: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibits120: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibits121: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibits122: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibits123: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibits124: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibits125: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibits126: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibits127: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibits128: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibits129: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibits130: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibits131: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibits132: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibits133: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibits134: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibits135: Chart on Regional Comparison - Europe
Exhibits136: Data Table on Regional Comparison - Europe
Exhibits137: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibits138: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibits139: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibits140: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibits141: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibits142: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibits143: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibits144: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibits145: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibits146: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibits147: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibits148: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibits149: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibits150: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibits151: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibits152: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibits153: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibits154: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibits155: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibits156: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibits157: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibits158: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibits159: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibits160: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibits161: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibits162: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibits163: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibits164: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibits165: Chart on Regional Comparison - Asia
Exhibits166: Data Table on Regional Comparison - Asia
Exhibits167: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibits168: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibits169: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibits170: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibits171: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibits172: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibits173: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibits174: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibits175: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibits176: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibits177: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibits178: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibits179: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibits180: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibits181: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibits182: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibits183: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibits184: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibits185: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibits186: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibits187: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibits188: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibits189: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibits190: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibits191: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibits192: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibits193: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibits194: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibits195: Chart on Regional Comparison - Rest of World (ROW)
Exhibits196: Data Table on Regional Comparison - Rest of World (ROW)
Exhibits197: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibits198: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibits199: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibits200: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibits201: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibits202: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibits203: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibits204: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibits205: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibits206: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibits207: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibits208: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibits209: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibits210: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibits211: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibits212: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibits213: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibits214: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibits215: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibits216: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibits217: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibits218: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibits219: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibits220: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibits221: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibits222: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibits223: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibits224: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibits225: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibits226: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibits227: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibits228: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibits229: Market opportunity by geography ($ million)
Exhibits230: Data Tables on Market opportunity by geography ($ million)
Exhibits231: Impact of drivers and challenges in 2025 and 2030
Exhibits232: Overview on criticality of inputs and factors of differentiation
Exhibits233: Overview on factors of disruption
Exhibits234: Impact of key risks on business
Exhibits235: Companies covered
Exhibits236: Company ranking index
Exhibits237: Matrix on companies position and classification
Exhibits238: Arrowhead Pharmaceuticals Inc. - Overview
Exhibits239: Arrowhead Pharmaceuticals Inc. - Product / Service
Exhibits240: Arrowhead Pharmaceuticals Inc. - Key offerings
Exhibits241: SWOT
Exhibits242: BioNTech SE - Overview
Exhibits243: BioNTech SE - Product / Service
Exhibits244: BioNTech SE - Key offerings
Exhibits245: SWOT
Exhibits246: Calando Pharmaceuticals Inc. - Overview
Exhibits247: Calando Pharmaceuticals Inc. - Product / Service
Exhibits248: Calando Pharmaceuticals Inc. - Key offerings
Exhibits249: SWOT
Exhibits250: Enzene Biosciences Ltd. - Overview
Exhibits251: Enzene Biosciences Ltd. - Product / Service
Exhibits252: Enzene Biosciences Ltd. - Key offerings
Exhibits253: SWOT
Exhibits254: Genevant Sciences Corp. - Overview
Exhibits255: Genevant Sciences Corp. - Product / Service
Exhibits256: Genevant Sciences Corp. - Key offerings
Exhibits257: SWOT
Exhibits258: Ionis Pharmaceuticals Inc. - Overview
Exhibits259: Ionis Pharmaceuticals Inc. - Product / Service
Exhibits260: Ionis Pharmaceuticals Inc. - Key offerings
Exhibits261: SWOT
Exhibits262: Merck and Co. Inc. - Overview
Exhibits263: Merck and Co. Inc. - Business segments
Exhibits264: Merck and Co. Inc. - Key news
Exhibits265: Merck and Co. Inc. - Key offerings
Exhibits266: Merck and Co. Inc. - Segment focus
Exhibits267: SWOT
Exhibits268: Novartis AG - Overview
Exhibits269: Novartis AG - Business segments
Exhibits270: Novartis AG - Key news
Exhibits271: Novartis AG - Key offerings
Exhibits272: Novartis AG - Segment focus
Exhibits273: SWOT
Exhibits274: OliX Pharmaceuticals Inc. - Overview
Exhibits275: OliX Pharmaceuticals Inc. - Product / Service
Exhibits276: OliX Pharmaceuticals Inc. - Key offerings
Exhibits277: SWOT
Exhibits278: Pfizer Inc. - Overview
Exhibits279: Pfizer Inc. - Business segments
Exhibits280: Pfizer Inc. - Key news
Exhibits281: Pfizer Inc. - Key offerings
Exhibits282: Pfizer Inc. - Segment focus
Exhibits283: SWOT
Exhibits284: Sanofi SA - Overview
Exhibits285: Sanofi SA - Business segments
Exhibits286: Sanofi SA - Key news
Exhibits287: Sanofi SA - Key offerings
Exhibits288: Sanofi SA - Segment focus
Exhibits289: SWOT
Exhibits290: Switch Therapeutics Inc. - Overview
Exhibits291: Switch Therapeutics Inc. - Product / Service
Exhibits292: Switch Therapeutics Inc. - Key offerings
Exhibits293: SWOT
Exhibits294: Sylentis S.A. - Overview
Exhibits295: Sylentis S.A. - Product / Service
Exhibits296: Sylentis S.A. - Key offerings
Exhibits297: SWOT
Exhibits298: Takeda Pharmaceutical Ltd. - Overview
Exhibits299: Takeda Pharmaceutical Ltd. - Business segments
Exhibits300: Takeda Pharmaceutical Ltd. - Key news
Exhibits301: Takeda Pharmaceutical Ltd. - Key offerings
Exhibits302: Takeda Pharmaceutical Ltd. - Segment focus
Exhibits303: SWOT
Exhibits304: Vir Biotechnology Inc. - Overview
Exhibits305: Vir Biotechnology Inc. - Product / Service
Exhibits306: Vir Biotechnology Inc. - Key offerings
Exhibits307: SWOT
Exhibits308: Inclusions checklist
Exhibits309: Exclusions checklist
Exhibits310: Currency conversion rates for US$
Exhibits311: Research methodology
Exhibits312: Information sources
Exhibits313: Data validation
Exhibits314: Validation techniques employed for market sizing
Exhibits315: Data synthesis
Exhibits316: 360 degree market analysis
Exhibits317: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/10/29 10:26

159.03 円

177.50 円

214.43 円

ページTOPに戻る